Navigation Links
Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
Date:9/10/2007

platform compatibility with

support for PS/2 and USB. The KL3116M with nanocoating technology is

priced at $2999.95

About ATEN Technology, Inc.

ATEN Technology, Inc. is an innovator of high-quality KVM (keyboard/video/mouse) and remote connectivity products to centrally manage servers, network devices and IT infrastructure. The company's local and remote server room and data center remote management solutions are widely used in SMB and enterprise-level environments. With more than 20 years of industry expertise and profitable growth, ATEN's product portfolio leverages a broad range of patents. Its leading-edge ASIC technology and VSE patents offer network administrators the most comprehensive features and functionality to manage growing multi-platform IT environments. The ASIC chip is one of the company's key differentiators, as it represents the innovation that drives the product line's capabilities, and ensures reliability and quality. ATEN has facilities in the United States, Taiwan, Belgium, Canada, Japan and China. The company's U.S. sales, marketing and warehouse operations are based in Irvine, California. For more information, contact ATEN at (888) 999-ATEN or 949-428- 1111, or via the Web at http://www.aten-usa.com.

(Disclaimer: Nanocoating properties may not protect users or others against bacteria, viruses, germs, or other disease organisms. This device cannot be used as antibiotic or anti-viral medication. Do not ingest the surface material of the device under any circumstances. If you have symptoms of bacteria or viral infection please consult with your physician and seek medical attention immediately. This device does not eliminate the entire universe of bacteria or viruses. It is not a replacement for cleanliness and good personal hygiene. Please keep your hands and work area clean for optimal protection.)

(C) Copyright ATEN 2007. All rights reserved.

A
'/>"/>

SOURCE ATEN Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Annual Meeting of the Consortium of Multiple Sclerosis Centers Focuses on the Challenges of Care and Research in Multiple Sclerosis
2. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
3. M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data at the AACR Annual Meeting
4. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
5. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes
8. Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show
9. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
10. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
11. AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin Cells Have the Ability to Recognize, Transport and Utilize L-ergothioneine (EGT) As A Protector Against Oxidative Damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Cellular Dynamics International ... iCell(TM) Cardiomyocytes for use in testing of new ... human heart cells are designed to aid drug ... efficacy and toxicity screens, weeding out ineffective and ... process before significant time and resources have been ...
(Date:12/15/2009)... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... 15, 2009 special dividend payment of $1.67 per share ... December 1, 2009. With this payment, distributions to ... $2.67 per share. In January 2010, the Company ... of the Company,s 2009 cash distributions and the allocation ...
(Date:12/15/2009)... Dec. 15 The U.S. Food and Drug ... today voted 12 yes, 4 no, and 1 abstention ... observed risks to support the use of CRESTOR® (rosuvastatin ... Men greater than or equal to 50 years, women ... Fasting LDL < 130 mg/dL; hsCRP greater than or ...
Breaking Medicine Technology:Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 2Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 3Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 4PDL BioPharma Completes December 15 Special Dividend Payment 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 3Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 4Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 5Teens Young Adults Need More Calcium 49403 1Teens Young Adults Need More Calcium 49403 2JourneyLite of Houston Receives Center of Excellence Accreditation 49400 1JourneyLite of Houston Receives Center of Excellence Accreditation 49400 2JourneyLite of Houston Receives Center of Excellence Accreditation 49400 3Childrens Named Among the Nations Top 10 Pediatric Hospitals by U S News 26 World Report 49396 1Childrens Named Among the Nations Top 10 Pediatric Hospitals by U S News 26 World Report 49396 2
(Date:12/15/2009)... a new electrophoretic method for detecting MIRCERA and ... technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity for ... of SDS-PAGE for detecting other EPOs. Details ... the World Anti-Doping Agency (WADA), appear in the ... published by Wiley-Blackwell. , MIRCERA (methoxy polyethylene ...
(Date:12/15/2009)... 15 The Food and Health Bureau has ... overseas parties in developing private hospitals at four sites ... for submitting EOI is March 31, 2010. ,, ... Health, Dr. York Chow, said the promotion of private ... reform and a major Hong Kong government policy announced ...
(Date:12/15/2009)... 15 Vitech Systems Group, a leading ... (CRM) software, announced today that it has completed ... the Screen Actors Guild-Producers Pension & Health Plans ... service capabilities to SAG-PH call center personnel in ... installed using Vitech,s V3 Benefits Administration System which ...
(Date:12/15/2009)... Diabetes Association and the CDC have released some sobering statistics concerning ... States. Treadmill desks offer employers an effective means of combating this ... ... December 14, 2009 -- Rates of diabetes are climbing across America ... rates. Despite this rise the American Diabetes Association has stated that ...
(Date:12/15/2009)... Team In Training (TNT), The Leukemia & Lymphoma ... program, has reached a remarkable milestone of raising ... patient services. ,, For more than 21 years, ... training program, preparing amateurs and seasoned athletes to ... cycle ride or hike adventure. Through the program,s ...
Breaking Medicine News(10 mins):Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3
... developed at the University at Buffalo has killed every ... airborne spores, viruses and bacteria in independent tests conducted ... prototype produced by Buffalo BioBlower Technologies LLC, a UB ... better than one part per million in an independent ...
... Dental Experts to Advance ... of CCLAD in Dentistry, LIVINGSTON, N.J., Feb. 28 ... leader in,advanced injection technologies, today reported that earlier this ... (CCLAD) Summit in New Orleans. The Summit welcomed a ...
... Out of Poverty on Average Pays,for Itself and ... LOS ANGELES, Feb. 28 Close to ... today at the Milken,Institute for the West Coast ... the United States economy through proven,investments in children. ...
... motivates people to stay active, helps reduce arthritis ... pain ... announced today a,partnership with McNeil Consumer Healthcare, the maker of TYLENOL(R),Arthritis ... and reduce arthritis pain. Through this new collaboration,participating YMCAs will introduce ...
... was issued by The Mesothelioma Applied Research, Foundation ... House, Energy and Commerce Committee on the "Bruce Vento ... Thursday, February 28, 2008. The Meso,Foundation is urging the ... step-up to the plate in allocating research funds for ...
... Commission Director General for Enterprise & Industry Heinz Zourek today ... an EC budget of 624 million to ESA as a ... , This will be provided in two stages: 419 million ... the GSC programme. Segment 2 will be submitted for subscription ...
Other Medicine News:Health News:UB's bioblower closer to protecting soldiers from biological attack 2Health News:UB's bioblower closer to protecting soldiers from biological attack 3Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 2Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 3Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 4Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 5Health News:Business Leaders, Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nation's Economy by Investing in Early Childhood 2Health News:Business Leaders, Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nation's Economy by Investing in Early Childhood 3Health News:YMCA of the USA and McNeil Consumer Healthcare Partner to Promote Health for Older Adults 2Health News:YMCA of the USA and McNeil Consumer Healthcare Partner to Promote Health for Older Adults 3Health News:Leading Asbestos-Cancer Group Urges Congress to Partner with Them and Support Funding Provisions in Asbestos Ban Legislation 2Health News:Leading Asbestos-Cancer Group Urges Congress to Partner with Them and Support Funding Provisions in Asbestos Ban Legislation 3Health News:Space sentinels: New 'tools' in space to improve European environment and security policies 2Health News:Space sentinels: New 'tools' in space to improve European environment and security policies 3
... INC. (CBI) Prolactin ELISA kit is used ... human serum or plasma. Human prolactin (lactogenic ... with a molecular weight of approximately 23,000 ... a solid phase direct sandwich ELISA method. ...
... Prolactin ELISA Kit is enzyme immunoassay ... Human Prolactin (PRL) concentration in serum. ... quantitative determination of many protein hormones ... accurate, sensitive, reproducible, rapid and specific ...
... This Enzyme-Linked Immunosorbent Assay (ELISA) serves the ... from plasma, serum and,urine. In a 1 ... samples is bound to an,available excess of ... to the surface of the microtitre plates. ...
... The AxSYM BNP assay allows you ... the status of your heart due ... versus NT-ProBNP. The AxSYM BNP assay ... simple, walk-away resultson a platform that ...
Medicine Products: